Identification Generic Name (2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE DrugBank Accession Number DB07081 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE (DB07081) ×  Close Weight Average: 421.3402  Monoisotopic: 421.133729421  Chemical Formula C 17 H 17 F 6 N 5 O Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Dipeptidyl peptidase 4 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as beta amino acids and derivatives. These are amino acids having a (-NH2) group attached to the beta carbon atom. Kingdom Organic compounds Super Class Organic acids and derivatives Class Carboxylic acids and derivatives Sub Class Amino acids, peptides, and analogues Direct Parent Beta amino acids and derivatives Alternative Parents Amphetamines and derivatives  /  Fluorobenzenes  /  Aralkylamines  /  Aryl fluorides  /  Triazoles  /  Tertiary carboxylic acid amides  /  Heteroaromatic compounds  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organofluorides  /  Organic oxides  /  Monoalkylamines  /  Hydrocarbon derivatives  /  Carbonyl compounds  /  Alkyl fluorides 
 
 
  show 5 more Substituents 1,2,4-triazole  /  Alkyl fluoride  /  Alkyl halide  /  Amine  /  Amphetamine or derivatives  /  Aralkylamine  /  Aromatic heteropolycyclic compound  /  Aryl fluoride  /  Aryl halide  /  Azacycle  /  Azole  /  Benzenoid  /  Beta amino acid or derivatives  /  Carbonyl group  /  Carboxamide group  /  Fluorobenzene  /  Halobenzene  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organofluoride  /  Organohalogen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary aliphatic amine  /  Primary amine  /  Tertiary carboxylic acid amide 
 
 
  show 22 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key FDEXEPZGMKFCTG-PSASIEDQSA-N InChI InChI=1S/C17H17F6N5O/c1-8-15-25-16(17(21,22)23)26-28(15)3-2-27(8)14(29)6-10(24)4-9-5-12(19)13(20)7-11(9)18/h5,7-8,10H,2-4,6,24H2,1H3/t8-,10-/m1/s1 IUPAC Name (3R)-3-amino-1-[(8R)-8-methyl-2-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one SMILES [H][C@](N)(CC(=O)N1CCN2N=C(N=C2[C@@]1([H])C)C(F)(F)F)CC1=C(F)C=C(F)C(F)=C1 References General References Not Available External Links PubChem Compound 23661697 PubChem Substance 99443552 ChemSpider 24682467 BindingDB 50221443 ChEMBL CHEMBL250787 ZINC ZINC000013982511 PDBe Ligand 448 PDB Entries 2qoe Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0279 mg/mL ALOGPS logP 2.16 ALOGPS logP 2.8 Chemaxon logS -4.2 ALOGPS pKa (Strongest Basic) 8.78 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 77.04 Å 2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 102.18 m 3 ·mol -1 Chemaxon Polarizability 34.86 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9491 Caco-2 permeable - 0.6137 P-glycoprotein substrate Substrate 0.7122 P-glycoprotein inhibitor I Inhibitor 0.6149 P-glycoprotein inhibitor II Inhibitor 0.568 Renal organic cation transporter Inhibitor 0.5604 CYP450 2C9 substrate Non-substrate 0.8972 CYP450 2D6 substrate Non-substrate 0.7453 CYP450 3A4 substrate Substrate 0.6709 CYP450 1A2 substrate Non-inhibitor 0.7056 CYP450 2C9 inhibitor Inhibitor 0.5102 CYP450 2D6 inhibitor Non-inhibitor 0.6926 CYP450 2C19 inhibitor Inhibitor 0.5656 CYP450 3A4 inhibitor Inhibitor 0.5892 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7235 Ames test Non AMES toxic 0.5539 Carcinogenicity Non-carcinogens 0.744 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.8536 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8307 hERG inhibition (predictor II) Inhibitor 0.6902    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 25 N/A N/A A29624 
 
 
  Details 
 
 
   Binding Properties 1.  Dipeptidyl peptidase 4 Kind Protein Organism Humans Pharmacological action Unknown General Function Virus receptor activity Specific Function Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by bindi... Gene Name DPP4 Uniprot ID P27487 Uniprot Name Dipeptidyl peptidase 4 Molecular Weight 88277.935 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:18 / Updated at June 12, 2020 16:52 